Side effects vary by individual, but many patients report better tolerance compared to other injectable medications
When comparing GLP-1 receptor agonists available in the UK, semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia) each demonstrate different nausea profiles based on clinical trial evidence and real-world data
Existing data suggest that the effects of GLP-1 on adipose tissue are primarily indirect
In the past, she had been on many therapies, including topicals, oral antibiotics, naltrexone, and photodynamic therapy and acitretin
In addition to injectable options, there is also an oral form of GLP-1 therapy available